Stock Comparison
ARGX vs MRNA
argenx NV ADR and Moderna Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$55.44B
$26.69B
P/E (TTM)
39.4
—
Forward P/E
34.0
23.0
Price/Sales
11.7
12.0
Price/Book
7.5
3.2
EV/EBITDA
33.9
4.6
Dividend Yield
—
—
Profitability
Net Margin
31.40%
-143.50%
Operating Margin
30.00%
-131.10%
Return on Equity
20.20%
-36.60%
Return on Assets
8.86%
-13.10%
Growth (YoY)
Revenue Growth
62.60%
260.20%
Earnings Growth
114.00%
-85.10%
Price & Risk
Beta
-0.0
1.0
52-Week High
$934.62
$69.28
52-Week Low
$510.06
$22.28
Analyst Target
$1,041.14
$43.45
Compare ARGX and MRNA your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.